Navigating Immune-related Toxicities
Navigating Immune-Related Toxicities: Insights on Monitoring, Treatment, and Prevention 

Released: January 16, 2025

Expiration: January 15, 2026

Alexa Basilio
Alexa Basilio, PharmD, BCOP
Jessica Davis
Jessica Davis, PharmD, BCOP, CPP

Activity

Progress
1
Course Completed

In this episode, Alexa Basilio, PharmD, BCOP and Jessica Davis, PharmD, BCOP, CPP discuss immune-related adverse events and toxicities among patients using immune checkpoint inhibitors. This overview will include discussion about:

  • How and when to monitor and treat mild vs severe immune-related toxicities
  • The art of balancing and tapering low-dose and high-dose corticosteroids
  • Differentiating between immune-related and chemotherapy- or targeted therapy–associated adverse events for optimal management approaches
  • Involvement of multidisciplinary teams early during treatment to prevent immune-related adverse events
  • Importance of educating patients, caregivers, and providers on immune-related toxicities